• Chronic 40 Hz Light Flicker Attenuates Epileptogenesis via d

  2026-04-18

  This study demonstrates that chronic 40 Hz light flicker (GENUS) can reduce epileptogenesis in a mouse model by strengthening gamma oscillations through a defined visual circuit involving the dorsal lateral geniculate nucleus (dLGN) shell. The findings highlight a non-invasive approach to modulate neuronal networks relevant for epilepsy, with implications for circuit-specific research and chemogenetic modulation strategies.

• 2,5-di-tert-butylbenzene-1,4-diol: Optimizing SERCA Inhibiti

  2026-04-17

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) from APExBIO stands out as a robust, selective SERCA inhibitor, empowering next-generation calcium signaling and stem cell mobilization assays. This article provides actionable workflow protocols, troubleshooting insights, and advanced application strategies for bench researchers seeking reproducibility and translational impact.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-04-16

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly sensitize tumors to ultra-high dose rate FLASH radiotherapy by boosting reactive oxygen species and DNA double-strand breaks, resulting in improved antitumor effects and immune activation. The work provides a mechanistic rationale and preclinical evidence for combining radiosensitizing nanoparticles with FLASH-RT to overcome its current limitations in tumor control.

• Coumestrol: Phytoestrogen Estrogen Receptor Antagonist in RA

  2026-04-15

  Coumestrol stands out as a selective phytoestrogen estrogen receptor antagonist, offering researchers a robust tool for dissecting nuclear receptor pathways and inducing ferroptosis in autoimmune models. This article translates the latest mechanistic findings into practical workflows, troubleshooting guidance, and protocol optimizations for leveraging Coumestrol (SKU C5832, APExBIO) in advanced selective estrogen receptor modulator (SERM) studies.

• Escitalopram in Molecular Psychiatry: Selectivity, Assay Pre

  2026-04-14

  Explore the molecular selectivity and translational importance of Escitalopram in advanced antidepressant research. This article uncovers nuanced assay strategies and integrates recent clinical findings to guide rigorous, reproducible study design.

• Linoleic Acid–PPARα–TF Axis Drives Tumor Progression in pLEL

  2026-04-13

  This study uncovers how linoleic acid induces tissue factor (TF) expression via PPAR-α activation, altering the tumor microenvironment and promoting progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC). The findings highlight the mechanistic role of lipid metabolism in rare lung cancer and suggest TF as a potential therapeutic target.

• Substance P (B6620): Technical Guide for Pain and Immune Res

  2026-04-13

  Substance P (SKU B6620) is a high-purity tachykinin neuropeptide for targeted research on pain transmission, immune modulation, and inflammation. This guide outlines practical handling, assay setup, and troubleshooting, helping researchers avoid common stability and solubility pitfalls. It is not intended for diagnostic or therapeutic applications beyond its defined research scope.

• Nonivamide: Bridging TRPV1 Mechanisms to Translational Impac

  2026-04-12

  Explore how Nonivamide, a capsaicin analog and selective TRPV1 agonist, is redefining translational research by uniting anti-proliferative and neuroimmune pathways. This article unpacks recent mechanistic breakthroughs, experimental protocols, and strategic guidance—grounded in rigorous evidence—to empower oncology and inflammation researchers.

• Oxaliplatin in Preclinical Oncology: Mechanisms, Resistance,

  2026-04-12

  Explore the multifaceted role of Oxaliplatin, a platinum-based chemotherapeutic agent, in cancer research. This article offers an in-depth analysis of its molecular action, resistance mechanisms, and practical assay guidance—delivering new insights beyond standard protocol reviews.

• Escitalopram in Antidepressant Research: Applied Workflows &

  2026-04-11

  Escitalopram (Lexapro) is the gold standard for dissecting serotonergic signaling, enabling reproducible and selective modeling of depression and anxiety. This article delivers actionable protocols, advanced troubleshooting, and translational insights for maximizing research performance with APExBIO's high-purity Escitalopram in neuropsychiatric studies.

• Lamotrigine in Blood-Brain Barrier and Epilepsy Research

  2026-04-11

  Lamotrigine’s dual action as a sodium channel blocker and 5-HT inhibitor, validated in high-throughput barrier models, sets new standards for CNS drug permeability and mechanistic epilepsy studies. Leveraging its high purity and solubility, researchers can streamline workflows from BBB penetration to sodium current modulation and arrhythmia assays.

• (6aR,9R)-N-((S)-1-hydroxybutan-2-yl)...maleate in 5-HT Assay

  2026-04-10

  (6aR,9R)-N-((S)-1-hydroxybutan-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide maleate is a serotonin receptor antagonist for use in 5-HT1/5-HT2 pathway research. It is best suited for in vitro assays requiring defined serotonin antagonism, but is not intended for diagnostic or clinical applications.

• Tropisetron Hydrochloride: Advanced Insights in Neurophar...

  2026-04-10

  Explore the multifaceted role of Tropisetron Hydrochloride as a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist in neuropharmacology research. This article delivers a distinct, in-depth analysis of serotonin receptor signaling, compound selectivity, and emerging experimental paradigms beyond typical applications.

• Clozapine N-oxide: Chemogenetic Actuator for Precise Neur...

  2026-04-09

  Clozapine N-oxide (CNO) stands as the gold-standard chemogenetic actuator, enabling selective and reversible modulation of neuronal circuits with unmatched specificity. By integrating APExBIO’s high-purity CNO into DREADDs workflows, researchers achieve robust, reproducible control over GPCR signaling pathways—fueling breakthroughs in neuropsychiatric and translational neuroscience research.

• Translating Mechanism into Impact: Strategic Utilization ...

  2026-04-08

  This thought-leadership article guides translational researchers through the advanced applications of Amitriptyline HCl in neuropharmacology. It provides mechanistic insight, strategic validation, and practical guidance for leveraging this serotonin/norepinephrine receptor inhibitor in blood-brain barrier models, neuropsychiatric disorder research, and signal transduction studies. Framing contemporary challenges and referencing clinical case studies, the article positions Amitriptyline HCl as a benchmark compound for the next generation of neuroscience discovery.

15644 records 1/1043 page Next 12345 下5页 Last page